XINHUA PHARM(SZ:000756)2022-12-06 11:28Group 1: Company Overview - Xinhua Pharmaceutical's chairman and financial officer introduced the company's history, development process, and current structure, which includes raw materials, formulations, and intermediates [2] - The company emphasizes its development advantages and strategic focus areas [2] Group 2: Research and Development - In 2015, the company increased its R&D investment to enhance future growth, focusing on eight key areas: analgesics, cardiovascular, anti-diabetic, central nervous system, digestive system, anti-infection, anti-tumor, and health products [3] - The company employs various methods, including self-research, collaboration, and outsourcing, to accelerate technological innovation and expand its product range [3] Group 3: Sales and Product Strategy - In 2015, the sales revenue from self-produced formulations remained stable compared to 2014, despite adjustments in product structure [3] - The company is focusing on five key products: Jianing, Shutaide, Jiahelu, Aidite, and is actively promoting large-scale formulation and international development strategies [3] Group 4: Consistency Evaluation and Partnerships - The company has established a dedicated team to advance the consistency evaluation of its formulation products, aiming to gain a competitive edge in the future [3] - Current collaborations with the Zibo Health and Family Planning Commission, JD.com, and Xinhua Pharmacy are still in the preparatory stage [3]